Caplin Point Lab

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE475E01026
  • NSEID: CAPLIPOINT
  • BSEID: 524742
INR
2,506.40
-12.6 (-0.5%)
BSENSE

Jun 25, 03:30 PM

BSE+NSE Vol: 81.42 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 640544,
    "name": "Caplin Point Lab",
    "stock_name": "Caplin Point Lab",
    "full_name": "Caplin Point Laboratories Ltd",
    "name_url": "stocks-analysis/caplin-point-lab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,506.40",
    "chg": -12.6,
    "chgp": "-0.5%",
    "dir": -1,
    "prev_price": "2,519.00",
    "mcapval": "18,935.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524742,
    "symbol": "CAPLIPOINT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE475E01026",
    "curr_date": "Jun 25, 03:30 PM",
    "curr_time": "23:02 PM",
    "last_traded_at": "Jun 25, 03:30 PM IST",
    "bse_nse_vol": "81.42 k",
    "exc_status": "Active",
    "traded_date": "Jun 25, 2026",
    "traded_date_str": "2026 06 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caplin-point-lab-640544-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Caplin Point Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4072428",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_technicaldot_4072428.png",
        "date": "2026-06-25 08:02:36",
        "description": "Caplin Point Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling renewed investor interest and potential upside in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Caplin Point Laboratories Ltd to 52-Week High of Rs 2587",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-new-52-week-high-at-rs2587-4069989",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_priceRelatedfactors_4069989.png",
        "date": "2026-06-24 09:44:11",
        "description": ""
      },
      {
        "title": "Caplin Point Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4068425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_mojoScore_4068425.png",
        "date": "2026-06-23 08:44:16",
        "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 22 June 2026. This revision reflects a nuanced assessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. While the company continues to demonstrate strong financial performance and management efficiency, evolving technical indicators and valuation metrics have prompted a more cautious stance."
      },
      {
        "title": "Caplin Point Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4066592",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_technicaldot_4066592.png",
        "date": "2026-06-22 08:01:45",
        "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in price momentum and technical indicators, prompting an upgrade in its Mojo Grade from Hold to Buy as of 16 June 2026. The stock’s recent surge, reflected in a 6.22% day change and a closing price near its 52-week high, signals renewed investor interest despite some mixed signals from key technical metrics."
      },
      {
        "title": "Caplin Point Laboratories Gains 3.93%: 7 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-gains-393-7-key-factors-driving-the-weeks-rally-4065664",
        "imagepath": "",
        "date": "2026-06-20 16:07:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> New 52-week high at Rs.2,445</p>\n                    <p><strong>16 Jun:</strong> Golden Cross formation signalling bullish breakout</p>\n                    <p><strong>17 Jun:</strong> Upgrade to Buy rating on strong technical and financials</p>\n                    <p><strong>19 Jun:</strong> New 52-week high at Rs.2,462 and intraday surge of 7.94%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,411.30</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,506.15</div>..."
      },
      {
        "title": "Caplin Point Laboratories Ltd Surges 7.94% to Day's High of Rs 2529 — Outperforms Sector by 6.57 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-intraday-high-with-794-surge-on-19-jun-2026-4063594",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_priceRelatedfactors_4063594.png",
        "date": "2026-06-19 15:31:15",
        "description": "The Sensex declined by 0.68% on 19 Jun 2026, while Caplin Point Laboratories Ltd surged 7.94%, touching an intraday high of Rs 2529. This 6.57-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally rather than a broad market lift."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Caplin Point Laboratories Ltd to 52-Week High of Rs 2462",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-new-52-week-high-at-rs2462-4063468",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_priceRelatedfactors_4063468.png",
        "date": "2026-06-19 12:35:16",
        "description": "With every major moving average breached and a strong confluence of technical indicators, Caplin Point Laboratories Ltd surged to a fresh 52-week high of Rs 2462 on 19 Jun 2026, marking a significant milestone in its price momentum."
      },
      {
        "title": "Caplin Point Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-4058384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_mojoScore_4058384.png",
        "date": "2026-06-17 08:24:19",
        "description": "Caplin Point Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 16 June 2026, is underpinned by robust quarterly results, a bullish technical outlook, and consistent long-term returns that have outpaced benchmark indices."
      },
      {
        "title": "Caplin Point Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4058124",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_technicaldot_4058124.png",
        "date": "2026-06-17 08:03:19",
        "description": "Caplin Point Laboratories Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a bullish stance. This change is underscored by a combination of moving averages, MACD, and Bollinger Bands signals, suggesting renewed investor confidence in the pharmaceuticals and biotechnology sector stock."
      }
    ],
    "total": 637,
    "sid": "640544",
    "stock_news_url": "https://www.marketsmojo.com/news/caplin-point-laboratories-640544"
  },
  "announcements": [
    {
      "details": "Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated December 03, 2019, titled \"CAPLIN STERILES GETS USFDA APPROVAL FOR SODIUM NITROPRUSSIDE INJECTION\".",
      "source": "NSE",
      "caption": "Caplin Point Laboratories Limited - Press Release",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Caplin Point Laboratories Limited has informed the Exchange regarding 'Notice of Postal Ballot'.",
      "source": "NSE",
      "caption": "Caplin Point Laboratories Limited - Updates",
      "datetime": "22-Nov-2019"
    },
    {
      "details": "Caplin Point Laboratories Limited has informed the Exchange regarding Reappointment of Director of the company.",
      "source": "NSE",
      "caption": "Caplin Point Laboratories Limited - Reappointment",
      "datetime": "31-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16",
          "dt": "2016-10-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Caplin Point Laboratories Gains 3.93%: 7 Key Factors Driving the Week’s Rally

2026-06-20 16:07:07

Key Events This Week

15 Jun: New 52-week high at Rs.2,445

16 Jun: Golden Cross formation signalling bullish breakout

17 Jun: Upgrade to Buy rating on strong technical and financials

19 Jun: New 52-week high at Rs.2,462 and intraday surge of 7.94%

stock-recommendationAnnouncement

Caplin Point Laboratories Limited - Press Release

03-Dec-2019 | Source : NSE

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated December 03, 2019, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR SODIUM NITROPRUSSIDE INJECTION".

Caplin Point Laboratories Limited - Updates

22-Nov-2019 | Source : NSE

Caplin Point Laboratories Limited has informed the Exchange regarding 'Notice of Postal Ballot'.

Caplin Point Laboratories Limited - Reappointment

31-Oct-2019 | Source : NSE

Caplin Point Laboratories Limited has informed the Exchange regarding Reappointment of Director of the company.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Caplin Point Laboratories Ltd has declared 200% dividend, ex-date: 29 May 26

stock-summary
SPLITS

Caplin Point Laboratories Ltd has announced 2:10 stock split, ex-date: 19 Oct 16

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available